ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-13 |

Results: 13

THE BURDEN OF MIGRAINE TO THE INDIVIDUAL SUFFERER - A REVIEW

Authors: DAHLOF CGH SOLOMON GD

Citation: Cgh. Dahlof et Gd. Solomon, THE BURDEN OF MIGRAINE TO THE INDIVIDUAL SUFFERER - A REVIEW, European journal of neurology, 5(6), 1998, pp. 525-533

CARDIOVASCULAR SAFETY OF 5HT(1B 1D) AGONISTS - IS THERE A CAUSE FOR CONCERN/

Authors: DAHLOF CGH MATHEW N

Citation: Cgh. Dahlof et N. Mathew, CARDIOVASCULAR SAFETY OF 5HT(1B 1D) AGONISTS - IS THERE A CAUSE FOR CONCERN/, Cephalalgia, 18(8), 1998, pp. 539-545

SAFETY TRIAL WITH THE 5HT(1B 1D) AGONIST AVITRIPTAN (BMS-180048) IN PATIENTS WITH MIGRAINE WHO HAVE EXPERIENCED PRESSURE, TIGHTNESS, AND/ORPAIN IN THE CHEST, NECK, AND/OR THROAT FOLLOWING SUMATRIPTAN/

Authors: DAHLOF CGH FALK L RISENFORS M LEWIS CP

Citation: Cgh. Dahlof et al., SAFETY TRIAL WITH THE 5HT(1B 1D) AGONIST AVITRIPTAN (BMS-180048) IN PATIENTS WITH MIGRAINE WHO HAVE EXPERIENCED PRESSURE, TIGHTNESS, AND/ORPAIN IN THE CHEST, NECK, AND/OR THROAT FOLLOWING SUMATRIPTAN/, Cephalalgia, 18(8), 1998, pp. 546-551

HOW DOES SUMATRIPTAN NASAL SPRAY PERFORM IN CLINICAL-PRACTICE

Authors: DAHLOF CGH BOESHANSEN S CEDERBERG CG HARDEBO JE HENRIKSSON A

Citation: Cgh. Dahlof et al., HOW DOES SUMATRIPTAN NASAL SPRAY PERFORM IN CLINICAL-PRACTICE, Cephalalgia, 18(5), 1998, pp. 278-282

NARATRIPTAN

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, NARATRIPTAN, CNS DRUGS, 8(5), 1997, pp. 409-409

ZOLMITRIPTAN - A VIEWPOINT

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, ZOLMITRIPTAN - A VIEWPOINT, CNS DRUGS, 7(6), 1997, pp. 479-479

ACUTE TREATMENT OF MIGRAINE WITH ORAL AND SUBCUTANEOUS SUMATRIPTAN

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, ACUTE TREATMENT OF MIGRAINE WITH ORAL AND SUBCUTANEOUS SUMATRIPTAN, Cephalalgia, 17(5), 1997, pp. 559-560

ALNIDITAN IN THE ACUTE TREATMENT OF MIGRAINE ATTACKS - A SUBCUTANEOUSDOSE-FINDING STUDY

Authors: GOLDSTEIN J DAHLOF CGH DIENER HC OLESEN J SCHELLENS R SENARD JM SIMARD D STEINER TJ

Citation: J. Goldstein et al., ALNIDITAN IN THE ACUTE TREATMENT OF MIGRAINE ATTACKS - A SUBCUTANEOUSDOSE-FINDING STUDY, Cephalalgia, 16(7), 1996, pp. 497-502

A QUALITY-OF-LIFE QUESTIONNAIRE FOR ADOLESCENTS WITH CHRONIC HEADACHEOR MIGRAINE

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, A QUALITY-OF-LIFE QUESTIONNAIRE FOR ADOLESCENTS WITH CHRONIC HEADACHEOR MIGRAINE, Cephalalgia, 16(3), 1996, pp. 137-137

KETOPROFEN, PARACETAMOL AND PLACEBO IN THE TREATMENT OF EPISODIC TENSION-TYPE HEADACHE

Authors: DAHLOF CGH JACOBS LD

Citation: Cgh. Dahlof et Ld. Jacobs, KETOPROFEN, PARACETAMOL AND PLACEBO IN THE TREATMENT OF EPISODIC TENSION-TYPE HEADACHE, Cephalalgia, 16(2), 1996, pp. 117-123

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, HEALTH-RELATED QUALITY-OF-LIFE UNDER 6 MONTHS TREATMENT OF MIGRAINE -AN OPEN CLINIC-BASED LONGITUDINAL-STUDY, Cephalalgia, 15(5), 1995, pp. 414-422

HOW DOES SUMATRIPTAN PERFORM IN CLINICAL-PRACTICE

Authors: DAHLOF CGH

Citation: Cgh. Dahlof, HOW DOES SUMATRIPTAN PERFORM IN CLINICAL-PRACTICE, Cephalalgia, 15, 1995, pp. 21-28

MIGRAINE PATIENTS EXPERIENCE POORER SUBJECTIVE WELL-BEING QUALITY OF LIFE EVEN BETWEEN ATTACKS/

Authors: DAHLOF CGH DIMENAS E

Citation: Cgh. Dahlof et E. Dimenas, MIGRAINE PATIENTS EXPERIENCE POORER SUBJECTIVE WELL-BEING QUALITY OF LIFE EVEN BETWEEN ATTACKS/, Cephalalgia, 15(1), 1995, pp. 31-36

Risultati: 1-13 |